Chemed (Germany) Today

CXM Stock  EUR 400.00  6.00  1.52%   

Performance

Soft

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Chemed is trading at 400.00 as of the 22nd of February 2026. This is a 1.52% increase since the beginning of the trading day. The stock's lowest day price was 400.0. Chemed has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat soft performance during the last 90 days. The performance scores are derived for the period starting the 24th of November 2025 and ending today, the 22nd of February 2026. Click here to learn more.
Business Domain
Health Care Equipment & Services
Category
Healthcare
Classification
Health Care
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. The company has 14.11 M outstanding shares. More on Chemed

Moving together with Chemed Stock

  0.64SK3 Smurfit Kappa GroupPairCorr

Chemed Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Chemed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chemed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEOKevin McNamara
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, Health Care, Health Care Providers & Services, Medical Care, Healthcare (View all Sectors)
Chemed's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Chemed's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Chemed utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Chemed's leverage profile, showing how much of Chemed's resources are funded through borrowing.
Liquidity
Chemed cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Chemed has accumulated 549.58 M in total debt with debt to equity ratio (D/E) of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Chemed has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Chemed until it has trouble settling it off, either with new capital or with free cash flow. So, Chemed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemed to invest in growth at high rates of return. When we think about Chemed's use of debt, we should always consider it together with cash and equity.

Change In Cash

(93.53 Million)
Chemed (CXM) is traded on Frankfurt Exchange in Germany and employs 15,695 people. Chemed is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chemed's market, we take the total number of its shares issued and multiply it by Chemed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chemed classifies itself under Health Care Providers & Services sector and is part of Health Care industry. The entity has 14.11 M outstanding shares. Chemed has accumulated about 3.32 M in cash with 417.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.21.
Check Chemed Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Chemed is €5.82 Billion. The majority of Chemed outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemed to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemed. Please pay attention to any change in the institutional holdings of Chemed as this could imply that something significant has changed or is about to change at the company. Also note that nearly seventy-nine thousand ten invesors are currently shorting Chemed expressing very little confidence in its future performance.
Check Chemed Ownership Details

Chemed Historical Income Statement

At this time, Chemed's Net Interest Income is most likely to increase significantly in the upcoming years. The Chemed's current Interest Income is estimated to increase to about 17.6 M, while Total Revenue is projected to decrease to roughly 2.1 B. View More Fundamentals

Chemed Stock Against Markets

Chemed Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.86. Chemed recorded earning per share (EPS) of 15.96. The entity last dividend was issued on the 23rd of February 2026. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. CHEMED CORP operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15707 people. For more info on Chemed please contact Kevin McNamara at 513 762 6690 or go to https://www.chemed.com.

Chemed Quarterly Total Revenue

624.9 Million

Chemed Investment Alerts

Chemed has accumulated 549.58 M in total debt with debt to equity ratio (D/E) of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Chemed has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Chemed until it has trouble settling it off, either with new capital or with free cash flow. So, Chemed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemed to invest in growth at high rates of return. When we think about Chemed's use of debt, we should always consider it together with cash and equity.
Over 98.0% of Chemed shares are held by institutions such as insurance companies
Latest headline from news.google.com: Impax Asset Management Group plc Reduces Holdings in Chemed Corporation CHE - MarketBeat

Chemed Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chemed's market, we take the total number of its shares issued and multiply it by Chemed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Chemed Profitablity

Chemed's profitability indicators refer to fundamental financial ratios that showcase Chemed's ability to generate income relative to its revenue or operating costs. If, let's say, Chemed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Chemed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Chemed's profitability requires more research than a typical breakdown of Chemed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12.

Management Efficiency

Chemed has return on total asset (ROA) of 0.1297 % which means that it generated a profit of $0.1297 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2411 %, meaning that it generated $0.2411 on every $100 dollars invested by stockholders. Chemed's management efficiency ratios could be used to measure how well Chemed manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Chemed's Net Tangible Assets are most likely to increase significantly in the upcoming years. The Chemed's current Non Currrent Assets Other is estimated to increase to about 164.9 M, while Total Assets are projected to decrease to roughly 1.3 B.
Leadership effectiveness at Chemed is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Dividend Yield
0.0053
Operating Margin
0.1196
Profit Margin
0.1102
Forward Dividend Yield
0.0049
Beta
0.457

Technical Drivers

As of the 22nd of February, Chemed shows the mean deviation of 1.15, and Risk Adjusted Performance of 0.05. Chemed technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Chemed variance, maximum drawdown, and the relationship between the coefficient of variation and jensen alpha to decide if Chemed is priced correctly, providing market reflects its regular price of 400.0 per share.

Chemed Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Chemed Tanh Of Price Series is a hyperbolic price transformation function.

Chemed Outstanding Bonds

Chemed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chemed uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chemed bonds can be classified according to their maturity, which is the date when Chemed has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Chemed Predictive Daily Indicators

Chemed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Chemed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Chemed Forecast Models

Chemed's time-series forecasting models are one of many Chemed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Chemed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Chemed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEOs Directory Now

   

CEOs Directory

Screen CEOs from public companies around the world
All  Next Launch Module

Chemed Corporate Management

Elected by the shareholders, the Chemed's board of directors comprises two types of representatives: Chemed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemed. The board's role is to monitor Chemed's management team and ensure that shareholders' interests are well served. Chemed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemed's outside directors are responsible for providing unbiased perspectives on the board's policies.

Other Information on Investing in Chemed Stock

Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.